title: Eosinophilic oesophagitis.
abstract: Eosinophilic oesophagitis is a chronic immune-mediated inflammatory disorder of the oesophagus, characterized by symptoms of dysphagia or food bolus obstruction. Diagnosis is supported by typical histological findings. This article covers pertinent aspects of the disease, pathogenic explanations and treatment options.
authors.affiliation: Core Medical Trainee in the Department of Hepatology, King's College Hospital, London SE5 9RS.
authors.forename: Aaron S
authors.initials: AS
authors.lastname: Bancil
authors.affiliation: Clinical Research Fellow in the Department of Gastroenterology, St George's Hospital, London.
authors.forename: Rhys
authors.initials: R
authors.lastname: Hewett
authors.affiliation: Consultant in the Department of Gastroenterology, St George's Hospital, London.
authors.forename: Jamal O
authors.initials: JO
authors.lastname: Hayat
authors.affiliation: Consultant in the Department of Gastroenterology, St George's Hospital, London.
authors.forename: Andrew
authors.initials: A
authors.lastname: Poullis
mesh_terms: D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D019819:Budesonide / Q000627:therapeutic use; D016207:Cytokines / Q000276:immunology; D003680:Deglutition Disorders / Q000209:etiology / Q000628:therapy*; D004035:Diet Therapy; D057765:Eosinophilic Esophagitis / Q000150:complications / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D004940:Esophageal Stenosis / Q000209:etiology / Q000601:surgery*; D004945:Esophagoscopy; D000068298:Fluticasone / Q000627:therapeutic use; D006801:Humans; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*; D018418:Th2 Cells / Q000276:immunology
chemical_list: D000893:Anti-Inflammatory Agents; D016207:Cytokines; D054328:Proton Pump Inhibitors; D019819:Budesonide; D000068298:Fluticasone